Company intelligence / Profile preview

SciGro

Ownership: Private
Development stage: Other

Overview

SciGro, Inc. is a consulting and services firm specializing in the rapid translation of research and preclinical stage technologies into products for the pharmaceutical, biotechnology, medical diagnostics, and life sciences industries. The company provides scientific management, technology assessment, grant proposal assistance (SBIR/STTR), clinical protocol design, workflow optimization for labs, and product line management. Their principals have deep experience in monoclonal antibodies and cytometric technologies.

Modalities: Monoclonal antibody (consulting expertise)Small molecule (consulting expertise)
Industry: Drug Discovery Services

Partnerships

No major pharma/biotech partnerships disclosed—works with various clients on a consultancy basis

Beyond the preview

Go deeper on SciGro.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SciGro.

Explore the full profile